Hot Topics

Groundbreaking Open-Access Textbook Sets New Standard for Lung Cancer Navigation and Care  

2026-01-06T08:31:28-06:00January 5th, 2026|Hot Topics, Newsletter Articles, Press Releases, Your Community|

A groundbreaking new open-access textbook, “Lung Cancer Navigation and Care: A Comprehensive Guide for Navigators and Allied Health Professionals,” is now available. As the first site-specific, comprehensive clinical guide for lung cancer navigation, the textbook equips navigators and allied [...]

FDA Approves New Administration Method for Rybrevant (amivantamab) 

2025-12-18T16:07:50-06:00December 18th, 2025|Hot Topics, News, Science and Research|

On December 17, 2025, the U.S. Food and Drug Administration (FDA) approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for subcutaneous injection, commonly known as a shot. This approval included all the same uses of Rybrevant (amivantamab) that the FDA previously approved for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have an [...]

Breathing Again: Natalie’s Unexpected Journey Through Lung Cancer and Transplant

2025-12-01T10:03:14-06:00December 1st, 2025|Hot Topics, Newsletter Articles, Spotlights, Survivors, Women, Your Community|

Natalie lives in Atlanta with her husband and her dog Hershey. She loves to travel with her family and friends and is working her way through her restaurant bucket list. In her spare time, she works with different organizations by volunteering [...]

Go to Top